Why the study?
Differences in pathophysiology, clinical presentation, and outcomes of cardiovascular disease between men and women remain incompletely understood, and women are underrepresented in trials.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Known sex differences in CVD outcomes persist with ongoing trial and workforce underrepresentation; leaves open mechanisms and inclusion strategies.
Differences in pathophysiology, clinical presentation, and outcomes of cardiovascular disease in men and women have been known for decades, but are not fully understood; women are underrepresented in most cardiovascular trials. Furthermore, women remain a minority in interventional cardiology and clinical cardiac electrophysiology.
No takes yet. Share an insight, caveat, or question.
Sven Reek (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: